IIM
CCCC icon

INTECH Investment Management’s C4 Therapeutics CCCC Stock Holding History

INTECH Investment Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.5K Buy
+19,602
New +$67K ﹤0.01% 1962
2025
Q2 		– Sell
-53,606
Closed -$85.8K – 2488
2025
Q1 		$85.8K Buy
53,606
+23,456
+78% +$70K ﹤0.01% 2351
2024
Q4 		$109K Buy
30,150
+3,024
+11% +$15K ﹤0.01% 2196
2024
Q3 		$155K Buy
+27,126
New +$163K ﹤0.01% 1799

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

INTECH Investment Management's CCCC Position: Q2 2026 in Review

INTECH Investment Management opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 19,602 shares worth $91.5K. The stake represents ﹤0.01% of the portfolio and ranks #1962 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in CCCC as recently as Q1 2025.

INTECH Investment Management first reported a position in CCCC in Q3 2024 and has held it in 4 quarters since. The position peaked at $155K in Q3 2024. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • INTECH Investment Management held 19,602 shares of C4 Therapeutics worth $91.5K as of Q2 2026.
  • C4 Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1962 holding.
  • INTECH Investment Management first reported a position in C4 Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • INTECH Investment Management's C4 Therapeutics position peaked at $155K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.